# A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza

> **NCT02954354** · PHASE3 · COMPLETED · sponsor: **Shionogi** · enrollment: 1436 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Baloxavir Marboxil
- **DRUG:** Placebo to Baloxavir Marboxil
- **DRUG:** Oseltamivir
- **DRUG:** Placebo to Oseltamivir

## Key facts

- **NCT ID:** NCT02954354
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-08
- **Primary completion:** 2017-04-04
- **Final completion:** 2017-04-24
- **Target enrollment:** 1436 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954354, "A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02954354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*